Skip to main content
logo
CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
93.91
+0.85 (0.91%)
At close: Aug 31, 2026, 4:00 PM EDT
94.25
+0.34 (0.36%)
After-hours: Aug 31, 2026, 7:59 PM EDT

CVS Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
105,45599,852105,099102,23998,42894,06896,95594,87890,84087,98393,54589,48788,64784,94483,52380,95880,49076,65876,23773,548
Revenue Growth (YoY)
7.14%6.15%8.40%7.76%8.35%6.92%3.65%6.02%2.47%3.58%12.00%10.54%10.13%10.81%9.56%10.08%11.29%11.42%-10.02%
Cost of Revenue
90,34784,80292,12689,06585,32280,19284,81182,87077,85175,87679,93776,18775,31871,90369,98767,76666,78063,43262,95261,092
Gross Profit
15,10815,05012,97313,17413,10613,87612,14412,00812,98912,10713,60813,30013,32913,04113,53613,19213,71013,22613,28512,456
Selling, General & Admin
11,03610,93211,32110,85810,34710,58410,36410,49910,23610,13010,1709,7829,7059,5379,8019,6119,1869,3249,8499,190
Operating Expenses
11,03610,93211,32110,85810,34710,58410,36410,49910,23610,13010,1709,7829,7059,5379,8019,6119,1869,3249,8499,190
Operating Income
4,0724,1181,6522,3162,7593,2921,7801,5092,7531,9773,4383,5183,6243,5043,7353,5814,5243,9023,4363,266
Interest Expense
-757-774-787-784-763-785-758-752-732-716-690-693-686-589-552-566-583-586-608-602
Interest & Investment Income
641574594632487520755550394454268277274334323201146168367246
Other Non Operating Income (Expenses)
3132-88262928-79252425-72222222-128404242-14749
EBT Excluding Unusual Items
3,9873,9501,3712,1902,5123,0551,6981,3322,4391,7402,9443,1243,2343,2713,3783,2564,1293,5263,0482,959
Merger & Restructuring Charges
-10-12-17-110-32-51-63-1,227-102-60-239-105-664-43-117----1,389-20
Impairment of Goodwill
----5,725----------------431
Gain (Loss) on Sale of Assets
---483----------349-12-2,480--41--
Legal Settlements
----320-833-387----100-----99-5,220--484--
Other Unusual Items
------491------------89-363
Pretax Income
3,9773,9381,354-3,4821,6472,6172,1261052,3371,5802,7053,0192,5702,8793,150-4,4444,1293,0011,5702,145
Income Tax Expense
982981-1,56950863483550334569456658754656737818-1,0451,090646274558
Earnings From Continuing Operations
2,9952,9572,923-3,9901,0131,7821,623711,7681,1242,0472,2651,9142,1422,332-3,3993,0392,3551,2961,587
Net Income to Company
2,9952,9572,923-3,9901,0131,7821,623711,7681,1242,0472,2651,9142,1422,332-3,3993,0392,3551,2961,587
Minority Interest in Earnings
-16-1420158-321162-11-1-4-13-62-7-10-11011
Net Income
2,9792,9432,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,3061,598
Net Income to Common
2,9792,9432,943-3,9751,0211,7791,644871,7701,1132,0462,2611,9012,1362,334-3,4063,0292,3541,3061,598
Net Income Growth (YoY)
191.77%65.43%79.02%--42.32%59.84%-19.65%-96.15%-6.89%-47.89%-12.34%--37.24%-9.26%78.71%-8.84%5.89%-30.56%
Shares Outstanding (Basic)
1,2791,2731,2701,2691,2661,2611,2591,2591,2561,2601,2881,2871,2831,2831,3101,3151,3131,3121,3221,321
Shares Outstanding (Diluted)
1,2871,2791,2771,2691,2701,2641,2611,2591,2591,2671,2931,2901,2871,2911,3191,3151,3211,3281,3361,329
Shares Change (YoY)
1.34%1.19%1.27%0.79%0.87%-0.24%-2.48%-2.40%-2.18%-1.86%-1.97%-1.90%-2.57%-2.79%-1.27%-1.05%-0.45%0.45%-1.06%
EPS (Basic)
2.332.312.32-3.130.811.411.310.071.410.881.591.761.481.661.78-2.592.311.790.991.21
EPS (Diluted)
2.312.302.31-3.130.801.411.310.071.410.881.591.751.481.651.77-2.592.291.770.981.20
EPS Growth (YoY)
188.75%63.12%76.55%--43.23%60.23%-17.80%-96.05%-4.78%-46.67%-10.47%--35.37%-6.78%81.77%-9.05%5.36%-29.03%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
5,6543,4002,606981,2903,8131,092-1,4152,4514,198-3,5472,1715,3176,454-2,6408,5435,0352,5123,4084,913
Free Cash Flow Per Share
4.392.662.040.081.023.020.87-1.121.953.31-2.741.684.135.00-2.006.503.811.892.553.70
Dividend Per Share
0.6650.6650.6650.6650.6650.6650.6650.6650.6650.6650.6050.6050.6050.6050.5500.5500.5500.5500.5000.500
Dividend Growth (YoY)
0%0%0%0%0%0%9.92%9.92%9.92%9.92%10.00%10.00%10.00%10.00%10.00%10.00%10.00%10.00%-0%
Gross Margin
14.33%15.07%12.34%12.88%13.31%14.75%12.53%12.66%14.30%13.76%14.55%14.86%15.04%15.35%16.21%16.30%17.03%17.25%17.43%16.94%
Operating Margin
3.86%4.12%1.57%2.27%2.80%3.50%1.84%1.59%3.03%2.25%3.67%3.93%4.09%4.13%4.47%4.42%5.62%5.09%4.51%4.44%
Profit Margin
2.83%2.95%2.80%-3.89%1.04%1.89%1.70%0.09%1.95%1.26%2.19%2.53%2.14%2.51%2.79%-4.21%3.76%3.07%1.71%2.17%
Free Cash Flow Margin
5.36%3.40%2.48%0.10%1.31%4.05%1.13%-1.49%2.70%4.77%-3.79%2.43%6.00%7.60%-3.16%10.55%6.25%3.28%4.47%6.68%
EBITDA
5,1985,2332,7993,4503,9304,4462,9272,6703,9043,1154,5724,6454,7284,5054,7784,6315,6064,9514,5514,400
EBITDA Margin
4.93%5.24%2.66%3.37%3.99%4.73%3.02%2.81%4.30%3.54%4.89%5.19%5.33%5.30%5.72%5.72%6.97%6.46%5.97%5.98%
D&A For EBITDA
1,1261,1151,1471,1341,1711,1541,1471,1611,1511,1381,1341,1271,1041,0011,0431,0501,0821,0491,1151,134
EBIT
4,0724,1181,6522,3162,7593,2921,7801,5092,7531,9773,4383,5183,6243,5043,7353,5814,5243,9023,4363,266
EBIT Margin
3.86%4.12%1.57%2.27%2.80%3.50%1.84%1.59%3.03%2.25%3.67%3.93%4.09%4.13%4.47%4.42%5.62%5.09%4.51%4.44%
Effective Tax Rate
24.69%24.91%--38.49%31.91%23.66%32.38%24.35%28.86%24.32%24.98%25.52%25.60%25.97%-26.40%21.53%17.45%26.01%
Revenue as Reported
106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,81389,76488,92185,27883,84681,15980,63676,82676,60473,794
SEC Filings: 10-K · 10-Q